Frontiers in Pharmacology | Cardiovascular and Smooth Muscle Pharmacology

Review

Published on 10 Jan 2025

Interplay between energy metabolism and NADPH oxidase-mediated pathophysiology in cardiovascular diseases

in Cardiovascular and Smooth Muscle Pharmacology

Haipeng Jie
Jingjing Zhang
Shuzhen Wu
Luyao Yu
Shengnan Li
Bo Dong
Feng Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1503824

689 views

Review

Published on 07 Jan 2025

Gallic acid: a dietary metabolite’s therapeutic potential in the management of atherosclerotic cardiovascular disease

in Cardiovascular and Smooth Muscle Pharmacology

Xiao-Lan Zhao
Zhang-Jing Cao
Ke-Di Li
Fei Tang
Li-Yue Xu
Jing-Nan Zhang
Dong Liu
Cheng Peng
Hui Ao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1515172

563 views

Original Research

Published on 07 Jan 2025

Identification of ALEKSIN as a novel multi-IRF inhibitor of IRF- and STAT-mediated transcription in vascular inflammation and atherosclerosis

in Cardiovascular and Smooth Muscle Pharmacology

Aleksandra Antonczyk
Katarzyna Kluzek
Natalia Herbich
Mahdi Eskandarian Boroujeni
Bart Krist
Dorota Wronka
Anna Karlik
Lukasz Przybyl
Adam Plewinski
Joanna Wesoly

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1471182

847 views

Editorial

Published on 07 Jan 2025

Editorial: Chronobiology in cardiometabolic health and disease

in Cardiovascular and Smooth Muscle Pharmacology

Cristina Manuela Dragoi
Zhihong Yang
Baharan Fekry
Andrea Brenna

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1544963

400 views

Editorial

Published on 06 Jan 2025

Editorial: Insights in cardiovascular and smooth muscle pharmacology: 2023

in Cardiovascular and Smooth Muscle Pharmacology

Sönke Schildt
Daniel Reichart
Simon Lebek

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1544594

441 views

Editorial

Published on 06 Jan 2025

Editorial: Revealing the unconventional mechanisms of mitochondria-targeting drugs in heart-related diseases

in Cardiovascular and Smooth Muscle Pharmacology

Kaidi Ren
Yang Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1543291

264 views

Original Research

Published on 03 Jan 2025

Cardioprotective effects of the electrolyte solution sterofundin and the possible underlying mechanisms

in Cardiovascular and Smooth Muscle Pharmacology

Min Chen
Yingying Xiao
Jijian Zheng
Peibin Zhao
Lin Cheng
Chuan Jiang
Sixie Zheng
Zheng Wang
Sijuan Sun
Lincai Ye

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1449831

501 views

Original Research

Published on 03 Jan 2025

Assessing the relationships of 1,400 blood metabolites with abdominal aortic aneurysm: a Mendelian randomization study

in Cardiovascular and Smooth Muscle Pharmacology

Qian Guo
Xinghua Xu
Xiaohui Li
Yang Mao
Shengqiang Li
Yuxin Yao
Xiang Li
Yaxing Li
Jiayue Feng
Yan Shu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1514293

722 views

Case Report

Published on 03 Jan 2025

Antithrombotic therapy for a case report of acute myocardial infarction after laparoscopic radical cystectomy

in Cardiovascular and Smooth Muscle Pharmacology

Zilong Wang
Huisheng Yuan
Junhao Chu
Shishuai Duan
Zhihui Zhang
Changze Song
Muwen Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1477715

489 views

Original Research

Published on 20 Dec 2024

Tenecteplase: biochemical and clot lysis activity comparisons

in Cardiovascular and Smooth Muscle Pharmacology

Jan Bechmann
Ira Schmid
Simone Brand
Felix Miller
Chengzhi Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1498116

1,171 views

Review

Published on 17 Dec 2024

Anticoagulation approach in morbid obesity: a comprehensive review on venous thromboembolism management

in Cardiovascular and Smooth Muscle Pharmacology

Victorita Sorodoc
Andreea Asaftei
Alexandr Ceasovschih
Catalina Lionte
Simina Crisan
Mihai Constantin
Lucia Indrei
Laurentiu Sorodoc

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1457280

1,104 views

Correction

Published on 13 Dec 2024

Corrigendum: (Pro)renin receptor aggravates myocardial pyroptosis in diabetic cardiomyopathy through AMPK-NLRP3 pathway

in Cardiovascular and Smooth Muscle Pharmacology

Shengnan Li
Jingjing Zhang
Yuewen Zhao
Li Kang
Haipeng Jie
Bo Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1532331

486 views

Original Research

Published on 13 Dec 2024

Comparative analysis of mineralocorticoid receptor antagonists and renin-angiotensin system inhibitors/angiotensin receptor neprilysin inhibitor in heart failure with mildly reduced ejection fraction

in Cardiovascular and Smooth Muscle Pharmacology

Chia-Chen Lee
David Te-Wei Kuan
Kai-Chun Chang
Zheng-Wei Chen
Jen-Fang Cheng
Ting-Tse Lin
Lian-Yu Lin
Cho-Kai Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1507326

740 views

Original Research

Published on 12 Dec 2024

Brg1 and RUNX1 synergy in regulating TRPM4 channel in mouse cardiomyocytes

in Cardiovascular and Smooth Muscle Pharmacology

Tao Ban
Xianhui Dong
Ziyue Ma
Jing Jin
Jing Li
Yunfeng Cui
Yuyang Fu
Yongzhen Wang
Yadong Xue
Tingting Tong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1494205

741 views

Original Research

Published on 06 Dec 2024

Metabolomics study of APETx2 post-conditioning on myocardial ischemia-reperfusion injury

in Cardiovascular and Smooth Muscle Pharmacology

Jing Li
Yiyong Wei
Yi Wang
Yue Zhang
Ying Xu
Huanhuan Ma
Lulin Ma
Qingfan Zeng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1470142

637 views

Editorial

Published on 03 Dec 2024

Editorial: Cytochromes P450, their modulators and metabolites in cardiovascular function and disease

in Cardiovascular and Smooth Muscle Pharmacology

Adeniyi M. Adebesin
Richard Joseph Roman
William B. Campbell
John M. Seubert
Rheem A. Totah

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1531166

455 views

Navigation group

Articles

Interplay between energy metabolism and NADPH oxidase-mediated pathophysiology in cardiovascular diseases

Gallic acid: a dietary metabolite’s therapeutic potential in the management of atherosclerotic cardiovascular disease

Identification of ALEKSIN as a novel multi-IRF inhibitor of IRF- and STAT-mediated transcription in vascular inflammation and atherosclerosis

Editorial: Chronobiology in cardiometabolic health and disease

Editorial: Insights in cardiovascular and smooth muscle pharmacology: 2023

Editorial: Revealing the unconventional mechanisms of mitochondria-targeting drugs in heart-related diseases

Cardioprotective effects of the electrolyte solution sterofundin and the possible underlying mechanisms

Assessing the relationships of 1,400 blood metabolites with abdominal aortic aneurysm: a Mendelian randomization study

Antithrombotic therapy for a case report of acute myocardial infarction after laparoscopic radical cystectomy

Tenecteplase: biochemical and clot lysis activity comparisons

Anticoagulation approach in morbid obesity: a comprehensive review on venous thromboembolism management

Corrigendum: (Pro)renin receptor aggravates myocardial pyroptosis in diabetic cardiomyopathy through AMPK-NLRP3 pathway

Comparative analysis of mineralocorticoid receptor antagonists and renin-angiotensin system inhibitors/angiotensin receptor neprilysin inhibitor in heart failure with mildly reduced ejection fraction

Brg1 and RUNX1 synergy in regulating TRPM4 channel in mouse cardiomyocytes

Metabolomics study of APETx2 post-conditioning on myocardial ischemia-reperfusion injury

Editorial: Cytochromes P450, their modulators and metabolites in cardiovascular function and disease